Patients at Henry Ford Hospital now have a new cancer treatment available that offers an alternative cancer surgery, without the incision or hospital stay, treating patients in 15 minutes or less and returning them to their everyday lives.
The Edge™ Radiosurgery Suite is designed to perform advanced, non-invasive cancer procedures anywhere in the body – including the brain, spine, head and neck, adrenal gland, lung, liver and pancreas – with extreme precision and low toxicity.
It is the first unit in North America and only available at the Josephine Ford Cancer Institute at Henry Ford Hospital.
The Edge, created by Varian Medical Systems, uses new real-time tumor tracking technology and motion management capabilities, improving both safety and comfort for patients by protecting healthy tissue with sub-millimeter-accuracy. And its “cutting edge” beam offers the agility to treat tumors that may be difficult to reach surgically.
Treatments are typically outpatient and completed within the same week – with only one to five sessions.
Patients will begin treatment using the Edge this week at Henry Ford Hospital.
A pioneer in the use stereotactic radiation therapy, Henry Ford’s Department of Radiation Oncology has treated more than 4,000 patients using this specialized type of stereotactic radiation therapy.
And now, the Edge offers patients:
• Faster treatment: With a dose rate of up to 2,400 monitor units per minute, it offers rapid stereotactic treatments in only 10-20 minutes compared to other systems that can take well over an hour per session.
• Increased comfort: The six degrees (6D) of freedom treatment couch provides the accuracy, precision and flexibility needed to optimally position and adjust patients, allowing them to be comfortable and breathe freely during treatment.
• Real-time imaging: An advanced motion management package makes it possible to better compensate for tumor motion during treatment. The 2.5mm multi-leaf collimator provides a distinct cutting “edge” for radiosurgery treatments.
• Cost-effective medicine: The Edge can accurately treat the vast majority of what a proton beam center can do at a fraction of the cost of a proton unit.
“Henry Ford’s Department of Radiation Oncology has a long tradition of expertise with the most advanced radiation technologies, a heritage that will now continue with the addition the Edge,” says Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at Henry Ford.
“The Edge truly represents a novel platform in radiosurgery, offering a system that provides a fully-integrated solution for planning and administering radiosurgery treatments.”
“In radiosurgery, millimeters matter,” says neurosurgeon Steven N. Kalkanis, M.D., director of the Center for Cancer Surgery at Henry Ford. “The Edge radiosurgery suite is calibrated for sub-millimeter accuracy. That will help us rest assured that we are doing everything possible to protect normal tissues.”
Henry Ford Hospital was selected by Varian as the first site for the Edge in North American because it “represents and embodies clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them,” according to Chris Toth, vice president of marketing for Varian’s Oncology Systems business.
Henry Ford joins Champalimaud Foundation in Lisbon, Portugal, as the first two sites in the world with the Edge.
What is Stereotactic Radiation?
Stereotactic radiation is a procedure that precisely delivers intense radiation doses to tumor targets in one to five treatments. The goal of this non-invasive procedure is to destroy, or make inactive, the tumor while minimizing dose exposure to the surrounding healthy tissue.
The Latest on: Stereotactic Radiation
via Google News
The Latest on: Stereotactic Radiation
- Tim Tams and radiation therapy at Waikato Hospitalon October 30, 2019 at 4:45 pm
For brain tumours, planning time for high-dose stereotactic treatment can be cut from days to hours, thanks to the machine and its systems, and a more automated process means patients could spend ...
- Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumorson October 29, 2019 at 3:18 am
Stereotactic body radiotherapy (SBRT) is a standard treatment for inoperable early-stage NSCLC, with local control rates comparable to surgical series. Promising results have been achieved utilizing a ...
- Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How?on October 28, 2019 at 8:13 pm
Metastasis-directed therapy (MDT) with stereotactic ablative radiotherapy (SABR) has emerged as a promising complementary technique for the management of low-volume metastatic prostate cancer. Herein ...
- Experiencing radiotherapy: what to knowon October 28, 2019 at 4:59 am
ICON radiotherapy practices offer treatments that include external beam radiation therapy, stereotactic radiotherapy, stereotactic body radiation therapy, intensity modulated radiation therapy, ...
- Here's Why It Is Worth Buying Varian Medical Systems Stock Nowon October 25, 2019 at 6:58 am
This opportunity will be driven by evolving new standards of care and increasing the adoption of SRS (stereotactic radiosurgery) and SBRT (stereotactic body radiation therapy). The fourth quarter and ...
- Radiotherapy Market 2019 Global Analysis, Opportunities And Forecast To 2024on October 24, 2019 at 7:17 am
such as intensity-modulated radiotherapy (IMRT) and stereotactic radiotherapy (SRT). These innovations have led to improved patient outcomes by higher precision targeting and minimal toxicity to ...
- New treatment equipment coming to the Cape Breton Cancer Centreon October 24, 2019 at 4:00 am
The Cape Breton Cancer Centre will be equipped with stereotactic body radiation therapy in 2020. (Tom Ayers/CBC) More Cape Breton cancer patients will receive treatment on the island in the new year.
- European Symposium to Advance Adoption of MRI-Guided Radiation Therapyon October 24, 2019 at 12:00 am
The Symposium, titled "Five Years & Counting: Clinical Experience on MRIdian," will cover current and future applications for MRI-guided radiation therapy including on-table adaptive therapy and ...
- Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Regions, Data - Analysis and Forecast, 2019-2024on October 23, 2019 at 5:11 pm
The radiation therapy quality assurance phantoms market segmentation (based on therapy) is further segmented into photon beam radiation therapy, stereotactic radiation therapy, advanced 3-D conformal ...
- Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conferenceon October 22, 2019 at 5:35 pm
“We have now treated more than 3,000 pets on-protocol with radiation therapy, including more than 2,200 with stereotactic radiation,” explained Dr. Mauldin. “The good news is that many of them are ...
via Bing News